Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07290270
What this trial is testing

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Who this might be right for
Metastatic Prostate Cancer
Novartis Pharmaceuticals 170
Early research (Phase 1)Study completedNCT01400555
What this trial is testing

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate NeoplasmsProstate Cancer
Cougar Biotechnology, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT07161778
What this trial is testing

A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Barts & The London NHS Trust 55
Early research (Phase 1)Ended earlyNCT04404140
What this trial is testing

A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Who this might be right for
Castration-Resistant Prostatic Cancer
Hoffmann-La Roche 6
Early research (Phase 1)Active Not RecruitingNCT03874884
What this trial is testing

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia 70
Early research (Phase 1)UnknownNCT04108247
What this trial is testing

Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

Who this might be right for
Prostate Cancer Castration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 39
Early research (Phase 1)Active Not RecruitingNCT02123758
What this trial is testing

JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic NeoplasmsMetastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc. 57
Testing effectiveness (Phase 2)Looking for participantsNCT04633252
What this trial is testing

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

Who this might be right for
Cancer Of ProstateProstate Neoplasms
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT01534052
What this trial is testing

Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Astellas Pharma Inc 52
Early research (Phase 1)Looking for participantsNCT05519449
What this trial is testing

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerCastration Resistant Prostatic Cancer
Janux Therapeutics 272
Not applicableUnknownNCT03601143
What this trial is testing

Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients

Who this might be right for
Castration-resistant Prostate Cancer
Technical University of Munich 120
Testing effectiveness (Phase 2)Study completedNCT02034552
What this trial is testing

Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Neoplasms
Bayer 68
Testing effectiveness (Phase 2)Ended earlyNCT04179864
What this trial is testing

Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Epizyme, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT02429193
What this trial is testing

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

Who this might be right for
Castration-resistant Prostate Cancer
University Health Network, Toronto 16
Testing effectiveness (Phase 2)Study completedNCT04869488
What this trial is testing

A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 93
Early research (Phase 1)Active Not RecruitingNCT04109729
What this trial is testing

Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 39
Testing effectiveness (Phase 2)Ended earlyNCT03093272
What this trial is testing

Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 9
Not applicableActive Not RecruitingNCT04222634
What this trial is testing

Metastasis-directed Therapy in Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 18
Testing effectiveness (Phase 2)Study completedNCT02737332
What this trial is testing

Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sun Pharmaceutical Industries Limited 53
Testing effectiveness (Phase 2)Study completedNCT02825628
What this trial is testing

Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer Metastatic
DexTech Medical AB 55
Next Page